- Home
- TNXP vs GAME Comparison
TNXP vs GAME Comparison
Compare TNXP & GAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- GAME
- Stock Information
- Founded
- TNXP 2007
- GAME 2011
- Country
- TNXP United States
- GAME United States
- Employees
- TNXP N/A
- GAME N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- GAME
- Sector
- TNXP Health Care
- GAME
- Exchange
- TNXP Nasdaq
- GAME Nasdaq
- Market Cap
- TNXP 19.5M
- GAME 23.2M
- IPO Year
- TNXP N/A
- GAME 2009
- Fundamental
- Price
- TNXP $0.20
- GAME $0.89
- Analyst Decision
- TNXP Strong Buy
- GAME Strong Buy
- Analyst Count
- TNXP 2
- GAME 3
- Target Price
- TNXP $53.50
- GAME $3.67
- AVG Volume (30 Days)
- TNXP 51.5M
- GAME 322.8K
- Earning Date
- TNXP 11-12-2024
- GAME 11-14-2024
- Dividend Yield
- TNXP N/A
- GAME N/A
- EPS Growth
- TNXP N/A
- GAME N/A
- EPS
- TNXP N/A
- GAME N/A
- Revenue
- TNXP $11,291,000.00
- GAME $94,529,043.00
- Revenue This Year
- TNXP $62.53
- GAME $102.07
- Revenue Next Year
- TNXP $26.17
- GAME $17.85
- P/E Ratio
- TNXP N/A
- GAME N/A
- Revenue Growth
- TNXP 183.05
- GAME 159.34
- 52 Week Low
- TNXP $0.12
- GAME $0.65
- 52 Week High
- TNXP $22.08
- GAME $2.25
- Technical
- Relative Strength Index (RSI)
- TNXP 66.43
- GAME 53.05
- Support Level
- TNXP $0.17
- GAME $0.79
- Resistance Level
- TNXP $0.28
- GAME $1.10
- Average True Range (ATR)
- TNXP 0.02
- GAME 0.11
- MACD
- TNXP 0.01
- GAME -0.00
- Stochastic Oscillator
- TNXP 44.53
- GAME 40.00
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is a vertically integrated, digital media, entertainment and technology company that connects brands with gaming and youth culture audiences. The company's end-to-end platform includes Gaming Community Network (a "GCN"), a digital media company focused on gaming and esports audiences, Swingman LLC dba as Zoned, a gaming and lifestyle marketing agency, and Code Red Esports Ltd. The company's geographical segment includes the United Kingdom, the USA, and Spain. The company generates the majority of its revenue from the USA. The company's sources of revenue consist of Teams, Agency, and SaaS + Advertising.